Background/Aims The core needle biopsy (CNB), fine needle aspiration cytology (FNAC) and touch imprint cytology (TIC) are commonly used tools for the diagnosis of hepatic malignancies. However, little is known about the benefits and criteria for selecting appropriate technique among them in clinical practice. We aimed to compare the sensitivity of ultrasound-guided CNB, FNAC, TIC as well as combinations for the diagnosis of hepatic malignancies, and to determine the factors associated with better sensitivity in each technique.
Methods From January 2018 to December 2019, a total of 634 consecutive patients who received ultrasound-guided liver biopsies at the National Taiwan University Hospital was collected, of whom 235 with confirmed malignant hepatic lesions receiving CNB, FNAC and TIC simultaneously were enrolled for analysis. The clinical and procedural data were compared.
Results The sensitivity of CNB, FNAC and TIC for the diagnosis of malignant hepatic lesions were 93.6%, 71.9%, and 85.1%, respectively. Add-on use of FNAC or TIC to CNB provided additional sensitivity of 2.1% and 0.4%, respectively. FNAC exhibited a significantly higher diagnostic rate in the metastatic cancers (P=0.011), hyperechoic lesions on ultrasound (P=0.028), and those with depth less than 4.5 cm from the site of needle insertion (P=0.036).
Conclusions The sensitivity of CNB is superior to that of FNAC and TIC for the diagnosis of hepatic malignancies. Nevertheless, for shallow (depth <4.5 cm) and hyperechoic lesions not typical for primary liver cancers, FNAC alone provides excellent sensitivity.
Citations
Citations to this article as recorded by
Role of imaging-guided biopsy for hepatocellular carcinoma Roberto Cannella, Zachary T. Berman, Nikhil V. Tirukkovalur, Samer T. Tohme, Marta I. Minervini, Alessandro Furlan European Journal of Radiology.2025; 191: 112271. CrossRef
Novel and less invasive biomarker assays to measure liver ATP7B in Wilson disease patients Rosanna J. Jiang, Lucy Chen, Kimberly Amburgey, Danie P. M. La, Brodie Fischbacher, Erle M. Holgersen, Lucienne Ronco, Adam J. Gehring, Jordan J. Feld, Kahlin Cheung-Ong Scientific Reports.2025;[Epub] CrossRef
Combined fine needle aspiration cytology and core needle biopsy in the same setting: A two‐years’ experience Valeria Ciliberti, Elisabetta Maffei, Angela D'Ardia, Francesco Sabbatino, Bianca Serio, Antonio D'Antonio, Pio Zeppa, Alessandro Caputo Cytopathology.2024; 35(1): 78. CrossRef
Patient‐Derived Organoids as Therapy Screening Platforms in Cancer Patients Danial Khorsandi, Jia‐Wei Yang, Samuel Foster, Safoora Khosravi, Negar Hosseinzadeh Kouchehbaghi, Fahimeh Zarei, Yun Bin Lee, Farhana Runa, Ankit Gangrade, Leon Voskanian, Darbaz Adnan, Yangzhi Zhu, Zhaohui Wang, Vadim Jucaud, Mehmet Remzi Dokmeci, Xiling Advanced Healthcare Materials.2024;[Epub] CrossRef
Risk factors of non-diagnostic percutaneous liver tumor biopsy: a single-center retrospective analysis of 938 biopsies based on cause of error Shintaro Kimura, Miyuki Sone, Shunsuke Sugawara, Chihiro Itou, Takumi Oshima, Mizuki Ozawa, Rakuhei Nakama, Sho Murakami, Yoshiyuki Matsui, Yasuaki Arai, Masahiko Kusumoto Japanese Journal of Radiology.2024;[Epub] CrossRef
Usefulness of on‐site cytology of liver tumor biopsy in specimen sampling for cancer genomic profiling test Tasuku Nakabori, Yutaro Abe, Sena Higashi, Kaori Mukai, Risa Yoshioka, Yuki Morimoto, Yuki Koyanagi, Satoshi Tanada, Shigenori Nagata, Keiichiro Honma, Kazuyoshi Ohkawa Cancer Medicine.2023; 12(7): 7888. CrossRef
Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues Violetta Rosiek, Ksenia Janas, Beata Kos-Kudła Biomedicines.2023; 11(3): 842. CrossRef
Sensitivity of cytology in liver tumor biopsy and its significance in the prompt clinical diagnosis of non‐hepatocellular carcinoma Tasuku Nakabori, Yutaro Abe, Sena Higashi, Kaori Mukai, Azusa Shingetsu, Sanako Nishimura, Sayoko Tsuzaki, Ayumi Ryu, Satoshi Tanada, Shigenori Nagata, Keiichiro Honma, Kazuyoshi Ohkawa Cancer Medicine.2023; 12(11): 12336. CrossRef
Refining Liver Biopsy in Hepatocellular Carcinoma: An In-Depth Exploration of Shifting Diagnostic and Therapeutic Applications Zeno Spârchez, Rareș Crăciun, Iuliana Nenu, Lavinia Patricia Mocan, Mihaela Spârchez, Tudor Mocan Biomedicines.2023; 11(8): 2324. CrossRef
Reliability of combined fine needle aspiration and core needle biopsies in the diagnosis of liver lesions: An 8‐year institutional experience Yuan Shen, Evgeniya Angelova, Mariana Moreno Prats, Cecilia Clement, Vicki Schnadig, Heather Stevenson‐Lerner, Jing He Cytopathology.2022; 33(4): 472. CrossRef
Image-guided Percutaneous Biopsy of the Liver Ather Adnan, Rahul A. Sheth Techniques in Vascular and Interventional Radiology.2021; 24(4): 100773. CrossRef
Touch Imprint Intraoperative Flow Cytometry as a Complementary Tool for Detailed Assessment of Resection Margins and Tumor Biology in Liver Surgery for Primary and Metastatic Liver Neoplasms Georgios Markopoulos, Georgios Glantzounis, Anna Goussia, Georgios Lianos, Anastasia Karampa, George Alexiou, George Vartholomatos Methods and Protocols.2021; 4(3): 66. CrossRef
Biopsy or cytology for diagnosing hepatic focal lesions? Haeryoung Kim Clinical and Molecular Hepatology.2021; 27(2): 278. CrossRef
First
Prev
